Can-Fite Reports 2023 Financial Results and Clinical Update
Ewopharma acquired marketing rights for namodenoson in the treatment of pancreatic carcinoma ...
Source: marketscreener.com
Stay updated with breaking news from Fite Broadens. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ewopharma acquired marketing rights for namodenoson in the treatment of pancreatic carcinoma ...